Page last updated: 2024-08-25

bendamustine hydrochloride and Atrial Fibrillation

bendamustine hydrochloride has been researched along with Atrial Fibrillation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Argnani, L; Baumgartner, J; Broccoli, A; Carella, M; Casadei, B; Cavo, M; Coppola, PE; Hohensinner, P; Kazem, N; Koller, L; Laufer, G; Lolli, G; Morigi, A; Nanni, L; Niessner, A; Pellegrini, C; Sabattini, E; Stefoni, V; Steinlechner, B; Sulzgruber, P; Thaler, B; Wojta, J; Zinzani, PL1
Abramson, JS; Bartlett, NL; Booth, AM; Brander, DM; Brown, JR; Byrd, JC; Coutre, S; Ding, W; Erba, H; Kuzma, CS; Larson, RA; Little, RF; Litzow, M; Mandrekar, SJ; Nattam, S; Owen, C; Ruppert, AS; Smith, SE; Stone, RM; Woyach, JA1
Avigdor, A; Balasubramanian, S; Bartlett, NL; Chanan-Khan, A; Cramer, P; Demirkan, F; Dilhuydy, MS; Fraser, G; Goy, A; Grosicki, S; Hallek, M; Howes, A; Janssens, A; Karlsson, C; Loscertales, J; Mahler, M; Mato, A; Mayer, J; Panagiotidis, P; Pavlovsky, MA; Phelps, C; Pristupa, A; Pylypenko, H; Rule, S; Salman, M; Samoilova, O; Silva, RS; Sun, S; Villa, D1

Trials

3 trial(s) available for bendamustine hydrochloride and Atrial Fibrillation

ArticleYear
    Thrombosis and haemostasis, 2020, Volume: 120, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; C-Reactive Protein; CD28 Antigens; Comorbidity; Coronary Artery Bypass; Cytotoxicity, Immunologic; Elective Surgical Procedures; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Inflammation; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; T-Lymphocyte Subsets

2020
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.
    Leukemia, 2021, Volume: 35, Issue:10

    Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Hypertension; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Prognosis; Rituximab; Survival Rate

2021
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
    The Lancet. Oncology, 2016, Volume: 17, Issue:2

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Hemorrhage; Humans; Intention to Treat Analysis; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nausea; Neutropenia; Piperidines; Pyrazoles; Pyrimidines; Retreatment; Rituximab; Thrombocytopenia

2016